"We wish to confirm that the Company has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Emtricitabine and ...

Global pharma major Lupin Limited on Wednesday announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA ...

Erectile dysfunction (ED) is a common condition, and many people find that it is treatable with Viagra — sometimes called the “little blue pill” — and its generic form, sildenafil.

"This milestone reflects our unwavering commitment to addressing unmet patient needs by delivering high-quality, affordable medications," Granules Ltd Chairman & Managing Director Krishna Prasad ...

The approved drug is available in multiple strengths; 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, and 60 mg, it added. The company's product is the generic equivalent to Takeda Pharmaceuticals' Vyvanse ...

Cialis and its generic counterpart, tadalafil, have Food and Drug Administration (FDA) approval to treat erectile dysfunction. Learn more about our most trusted places to get this medication ...

In 2014, however, Patrick Coles and colleagues at the National University of Singapore showed theoretically that the two were equivalent. This has never been experimentally demonstrated, however. In ...

Rokon motorcycles aren’t like any other. This particular two-wheel-drive beast, the Ranger Dual Sport Edition, might not produce crazy power figures, but it can tow 2,000 lb (907 kg), climb a 60 ...

Hims offers brand-name Cialis as a monthly supply of 5-mg tablets you can take daily. Generic Cialis (tadalafil) is available in 2.5-mg, 5-mg, 10-mg, 15-mg, and 20-mg tablets for daily or as ...

At Novartis, he advanced the global strategy for Luxturna, the first approved ocular gene therapy. At Shire, he was instrumental in launching Xiidra, leading to its divestiture to Novartis for up to ...

Novartis’ decision to withdraw a European filing for its dry-eye drug Xiidra is to have a knock-on effect on Takeda, causing it to make a loss of $200 million this quarter. Already approved ...

Shire has launched its dry eye treatment Xiidra (lifitegrast) in the US, a drug the company hopes will achieve blockbuster status. The Dublin-based, London-listed company said Xiidra is available ...